Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
233 USD | +3.17% |
|
+9.12% | +0.47% |
Jul. 15 | ANI Pharmaceuticals Launches L-Glutamine Oral Powder Following FDA Approval | MT |
Jul. 15 | Leerink Partners Adjusts Price Target on IQVIA to $267 From $278, Maintains Outperform Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.47% | 41.16B | |
+26.73% | 46.56B | |
+45.38% | 41.67B | |
+31.75% | 32.4B | |
+20.93% | 28.18B | |
-6.35% | 28.1B | |
+49.50% | 14.52B | |
+48.27% | 13.74B | |
+3.60% | 12.17B | |
-3.77% | 11.14B |
- Stock Market
- Equities
- IQV Stock
- News Iqvia Holdings Inc.
- Transcript : IQVIA Holdings Inc. - Special Call